Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation

Alexander Kogan; Marius Berman; Ygal Kassif; Ehud Raanani; Alon Stamler; Tuvia Ben Gal; Michael Stein; Eldad Erez; Bernardo A. Vidne; Gideon Sahar

doi:10.1016/j.healun.2003.12.001

Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation

Alexander Kogan, Marius Berman, Ygal Kassif, Ehud Raanani, Alon Stamler, Tuvia Ben Gal, Michael Stein, Eldad Erez, Bernardo A. Vidne, Gideon Sahar

Research output: Contribution to journal › Short survey › peer-review

13 Scopus citations

Abstract

A 48-year-old man undergoing orthotopic heart transplantation for ischemic cardiomyopathy developed severe right heart failure. Severe intractable bleeding complicated implantation of a right ventricular assist device. Treatment with 9.6 mg of recombinant activated factor VII stopped the bleeding, and the patient could be transferred to the intensive care unit. This is the first reported case of the successful use of recombinant activated factor VII to control bleeding with subsequent right ventricular assist device function.

Original language	English
Pages (from-to)	347-349
Number of pages	3
Journal	Journal of Heart and Lung Transplantation
Volume	24
Issue number	3
DOIs	https://doi.org/10.1016/j.healun.2003.12.001
State	Published - 1 Jan 2005
Externally published	Yes

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine
Transplantation

Access to Document

10.1016/j.healun.2003.12.001

Cite this

@article{9fe7ae35c10549068bb87a68a97a78d0,

title = "Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation",

abstract = "A 48-year-old man undergoing orthotopic heart transplantation for ischemic cardiomyopathy developed severe right heart failure. Severe intractable bleeding complicated implantation of a right ventricular assist device. Treatment with 9.6 mg of recombinant activated factor VII stopped the bleeding, and the patient could be transferred to the intensive care unit. This is the first reported case of the successful use of recombinant activated factor VII to control bleeding with subsequent right ventricular assist device function.",

author = "Alexander Kogan and Marius Berman and Ygal Kassif and Ehud Raanani and Alon Stamler and {Ben Gal}, Tuvia and Michael Stein and Eldad Erez and Vidne, {Bernardo A.} and Gideon Sahar",

year = "2005",

month = jan,

day = "1",

doi = "10.1016/j.healun.2003.12.001",

language = "English",

volume = "24",

pages = "347--349",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation

AU - Kogan, Alexander

AU - Berman, Marius

AU - Kassif, Ygal

AU - Raanani, Ehud

AU - Stamler, Alon

AU - Ben Gal, Tuvia

AU - Stein, Michael

AU - Erez, Eldad

AU - Vidne, Bernardo A.

AU - Sahar, Gideon

PY - 2005/1/1

Y1 - 2005/1/1

N2 - A 48-year-old man undergoing orthotopic heart transplantation for ischemic cardiomyopathy developed severe right heart failure. Severe intractable bleeding complicated implantation of a right ventricular assist device. Treatment with 9.6 mg of recombinant activated factor VII stopped the bleeding, and the patient could be transferred to the intensive care unit. This is the first reported case of the successful use of recombinant activated factor VII to control bleeding with subsequent right ventricular assist device function.

AB - A 48-year-old man undergoing orthotopic heart transplantation for ischemic cardiomyopathy developed severe right heart failure. Severe intractable bleeding complicated implantation of a right ventricular assist device. Treatment with 9.6 mg of recombinant activated factor VII stopped the bleeding, and the patient could be transferred to the intensive care unit. This is the first reported case of the successful use of recombinant activated factor VII to control bleeding with subsequent right ventricular assist device function.

UR - http://www.scopus.com/inward/record.url?scp=20044396525&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2003.12.001

DO - 10.1016/j.healun.2003.12.001

M3 - Short survey

C2 - 15737765

AN - SCOPUS:20044396525

SN - 1053-2498

VL - 24

SP - 347

EP - 349

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 3

ER -

Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this